Full Context · Biotech & Pharma · latest Fri 10.23.2026
IgA nephropathy
Picked by hand from the editions. Every block below is the edition's own text, with its edition and date.
The latest
A back issue. Members of Biotech & Pharma can read it.
What changed
Earlier coverage, newest first
A back issue. Members of Biotech & Pharma can read it.
Evidence
Checked against the source
A back issue. Members of Biotech & Pharma can read it.
A back issue. Members of Biotech & Pharma can read it.
A back issue. Members of Biotech & Pharma can read it.
A back issue. Members of Biotech & Pharma can read it.
Disagreement
The case against, and what would settle it
A back issue. Members of Biotech & Pharma can read it.
From the other briefs
None picked. The other briefs have not covered this story.